{"altmetric_id":2412446,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) trial has recently reported.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ec3cf058f6100029cd","authors":["Andrew Briggs","Borislava Mihaylova","Mark Sculpher","Alistair Hall","Jane Wolstenholme","Maarten Simoons","Jaap Deckers","Roberto Ferrari","Willem J Remme","Michel Bertrand","Kim Fox"],"doi":"10.1136\/hrt.2005.086728","first_seen_on":"2014-06-08T22:36:29+00:00","issns":["1468-201X"],"issue":"9","journal":"Heart","last_mentioned_on":1449792000,"links":["http:\/\/dx.doi.org\/10.1136\/hrt.2005.086728"],"pmid":"17135223","pubdate":"2007-01-09T00:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["cardiology"],"title":"Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study","type":"article","volume":"93","mendeley_url":"http:\/\/www.mendeley.com\/research\/cost-effectiveness-perindopril-reducing-cardiovascular-events-patients-stable-coronary-artery-diseas-5"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8148077,"mean":6.9006807989945,"rank":2058160,"this_scored_higher_than_pct":61,"this_scored_higher_than":4972837,"rank_type":"exact","sample_size":8148077,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":178710,"mean":7.3798858031775,"rank":47105,"this_scored_higher_than_pct":71,"this_scored_higher_than":127044,"rank_type":"exact","sample_size":178710,"percentile":71},"this_journal":{"total_number_of_other_articles":2651,"mean":12.490099622642,"rank":964,"this_scored_higher_than_pct":52,"this_scored_higher_than":1401,"rank_type":"exact","sample_size":2651,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":135,"mean":8.646223880597,"rank":42,"this_scored_higher_than_pct":68,"this_scored_higher_than":93,"rank_type":"exact","sample_size":135,"percentile":68}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Ph. D. Student":2,"Professor":3},"by_discipline":{"Medicine and Dentistry":3,"Agricultural and Biological Sciences":1,"Business, Management and Accounting":1}}}},"posts":{"policy":[{"title":"Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/TA388\/documents\/committee-papers","license":"public","citation_ids":[15786406,5531230,4884969,5736641,15786425,15786450,2923437,15786461,9648202,6337128,2096733,4307593,1907008,15660205,15786476,2854906,21734683,9683320,1592693,8253344,15786493,4928497,2412446,1145378,15786702,15786891,15786900,15786905,15786908,5757408,15786914,15786920,15786926,15786933,15773264,15786938,8262121,15786944,2763751,15786953,21734685,6337248,15772890,8245114,15786963,15786968,15786974,2420886,21734686,14598178,15773139,5768287,21734690,13415697,2185425,913128,2675751,15773313,21734691,2412926,2412990,15773894,14717973,15787029,21673302,15787034,1117279,5582202,1715311,2360752,21734697,210254,15787052,12595225,15787067,7418409,11849405,15787087,15787099,15777109,15787112,15787126,15787137,15787144,15787153,183575,5910352,1118217,15773311,15787319,4466942,21734728,2850103,109583,7435216,15787503,913119,1663133,1623808,21734736,2900199,3191913,15336735,15787524,10949123,7403017,21734739,4041379,15787538,2353621,15787546,15787551,15787557,21734743,15787570,766561,4116990,15787606,15787615,15787630,7407056,8586373,15787647,15787663,15773900,15787666,21734750,15787678,15787682,21734751,21734754,15787688,15787691,15787701,15787709,2666885,15787719,3213597,5760582,15787734,227684,15787741,21734759,580144,2416201,15787755,15787765,15787768,7413314,15787780,15787784,21734773,21734775,15787793,7274505,15787803,3598996,15787814,15787821,15787824,15787834,15787843,15787849,1975061,15787863,15787873,2477026,15777107,15788040,15788045,15773334,21734793,4769800,2036168,13007507,15788082,7411568,6566892,6235964,2414663,854699,5496824,2414666,3213579,173695,2640669,15788096,15772885,1534660],"posted_on":"2015-12-11T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta388\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-8bdb161a7ffa711c88565f36724bbaeb205e30da1ff817d8e9914ed4d8fc33bf.jpg"}}]}}